Search

everythinglearnresearchcommunity

for

Search:↓

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Androgens may block hair growth signals, targeting this could treat hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Melatonin protects skin against UV damage by regulating various cellular processes.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.